Safety of endoscopic sphincterotomy in patients undergoing antithrombotic treatment

Safety of endoscopic sphincterotomy in patients undergoing antithrombotic treatment - Endoscopic sphincterotomy undergoing antithrombotic treatment

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000030031

Enrollment

Registered

2017-11-19

Start date

2017-05-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreas and biliary tract disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients undergoing antithrombotic treatment Patients who underwent endoscopic sphincterotomy Patients with naive papilla

Exclusion criteria

Exclusion criteria: Patients with altered gastrointestinal anatomy

Design outcomes

Primary

Measure	Time frame
The incidence of adverse events	—

Countries

Japan

Contacts

Public ContactKatsuya Kitamura

Showa University School of Medicine Division of Gastroenterology, Department of Medicine

k.kitamura@med.showa-u.ac.jp03-3784-8535

Outcome results